These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 37963310)
21. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW; Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645 [TBL] [Abstract][Full Text] [Related]
22. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence. Makis W; Kurzencwyg D; Hickeson M Clin Imaging; 2013; 37(6):1094-7. PubMed ID: 23993799 [TBL] [Abstract][Full Text] [Related]
23. Management of recurrent colorectal cancer: another look at carcinoembryonic antigen-detected recurrence. Vauthey JN; Dudrick PS; Lind DS; Copeland EM Dig Dis; 1996; 14(1):5-13. PubMed ID: 8719729 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic Accuracy of Carcinoembryonic Antigen (CEA) in Detecting Colorectal Cancer Recurrence Depending on Its Preoperative Level. Lee TH; Kim JS; Baek SJ; Kwak JM; Kim J J Gastrointest Surg; 2023 Aug; 27(8):1694-1701. PubMed ID: 37407895 [TBL] [Abstract][Full Text] [Related]
25. Machine Learning Algorithms for Predicting the Recurrence of Stage IV Colorectal Cancer After Tumor Resection. Xu Y; Ju L; Tong J; Zhou CM; Yang JJ Sci Rep; 2020 Feb; 10(1):2519. PubMed ID: 32054897 [TBL] [Abstract][Full Text] [Related]
26. Perioperative cell-free DNA trends predict recurrence of non-metastatic colorectal cancer significantly earlier than CEA trends over the first 2 years post-operatively in stage II and stage III colon cancer. Fleming CA; Jordan P; O'Leary DP; Corrigan MA; Wang JH; Redmond HP Int J Colorectal Dis; 2022 May; 37(5):1119-1126. PubMed ID: 35441872 [TBL] [Abstract][Full Text] [Related]
27. Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computerized tomography, and physical examination. Sardi A; Agnone CM; Nieroda CA; Mojzisik C; Hinkle G; Ferrara P; Farrar WB; Bolton J; Thurston MO; Martin EW South Med J; 1989 Oct; 82(10):1235-44. PubMed ID: 2799440 [TBL] [Abstract][Full Text] [Related]
28. Elevated serum carcinoembryonic antigen level after curative surgery is a prognostic biomarker of stage II-III colorectal cancer. Sonoda H; Yamada T; Matsuda A; Ohta R; Shinji S; Yokoyama Y; Takahashi G; Iwai T; Takeda K; Ueda K; Kuriyama S; Miyasaka T; Yoshida H Eur J Surg Oncol; 2021 Nov; 47(11):2880-2887. PubMed ID: 34103245 [TBL] [Abstract][Full Text] [Related]
29. Significance of postoperative serum level of carcinoembryonic antigen (CEA) and actual half life of CEA in colorectal cancer patients. Choi JS; Min JS Yonsei Med J; 1997 Feb; 38(1):1-7. PubMed ID: 9100477 [TBL] [Abstract][Full Text] [Related]
30. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401 [TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection. Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887 [TBL] [Abstract][Full Text] [Related]
32. Carcinoembryonic antigen (CEA) testing in colorectal cancer follow up: what do patients think? Steele N; Haigh R; Knowles G; Mackean M Postgrad Med J; 2007 Sep; 83(983):612-4. PubMed ID: 17823231 [TBL] [Abstract][Full Text] [Related]
33. A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer. Huang YY; Lee PI; Liu MC; Chen CC; Huang KC; Huang AT Clin Nucl Med; 2015 Oct; 40(10):e465-9. PubMed ID: 26204213 [TBL] [Abstract][Full Text] [Related]
34. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer. Irvine T; Scott M; Clark CI Colorectal Dis; 2007 Jul; 9(6):527-31. PubMed ID: 17573747 [TBL] [Abstract][Full Text] [Related]
35. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study. Hara M; Kanemitsu Y; Hirai T; Komori K; Kato T Dis Colon Rectum; 2008 Nov; 51(11):1675-80. PubMed ID: 18633674 [TBL] [Abstract][Full Text] [Related]
36. Utility of postoperative CEA for surveillance of recurrence after resection of primary colorectal cancer. Bhatti I; Patel M; Dennison AR; Thomas MW; Garcea G Int J Surg; 2015 Apr; 16(Pt A):123-128. PubMed ID: 25771102 [TBL] [Abstract][Full Text] [Related]
37. THE Role of Preoperative carcinoembryonic antigen in recurrence of resectable colorectal carcinoma. Khan MA; Maken RN; Nisar H; Fatima I; Khan IU; Masood M; Shahid AB Acta Clin Croat; 2020 Jun; 59(2):216-222. PubMed ID: 33456107 [TBL] [Abstract][Full Text] [Related]
38. Sub-classification of Stage II colorectal cancer based on clinicopathological risk factors for recurrence. Hashimoto T; Itabashi M; Ogawa S; Hirosawa T; Bamba Y; Shimizu S; Kameoka S Surg Today; 2014 May; 44(5):902-5. PubMed ID: 24356986 [TBL] [Abstract][Full Text] [Related]
39. Machine learning for predicting colon cancer recurrence. Kayikcioglu E; Onder AH; Bacak B; Serel TA Surg Oncol; 2024 Jun; 54():102079. PubMed ID: 38688191 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis. Körner H; Söreide K; Stokkeland PJ; Söreide JA Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]